CERIDIAN HCM HOLDING INC (CDAY.CA) Forecast, Price Target & Analyst Ratings
TSX:CDAY • US15677J1088
92.28 CAD
+0.34 (+0.37%)
Last: Mar 20, 2024, 07:00 PM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for CERIDIAN HCM HOLDING INC (CDAY.CA).
Forecast Snapshot
Consensus Price Target
CA$105.21
+ 14.01% Upside
Next Earnings Forecast
Release DateFeb 8, 2022
PeriodQ4 / 2023
EPS Estimate$0.33
Revenue Estimate407.7M
ChartMill Buy Consensus
76.67%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
CA$105.21
Upside
+ 14.01%
From current price of CA$92.28 to mean target of CA$105.21, Based on 24 analyst forecasts
Low
CA$84.57
Median
CA$103.32
High
CA$134.71
Price Target Revisions
1 Month
0.00%
3 Months
0.83%
Price Target Summary
24 analysts have analysed CDAY.CA and the average price target is 105.21 CAD. This implies a price increase of 14.01% is expected in the next year compared to the current price of 92.28.
The average price target has been revised upward by 0.83% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
76.67%
CDAY.CA was analyzed by 24 analysts. The buy percentage consensus is at 77. So analysts seem to be have mildly positive about CDAY.CA.
In the previous month the buy percentage consensus was at a similar level.
CDAY.CA was analyzed by 24 analysts, which is quite many. So the average rating should be quite meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2022-08-05 | Morningstar | Initiate | Buy |
| 2021-11-02 | Deutsche Bank | Initiate | Buy |
| 2021-08-05 | Piper Sandler | Maintains | Neutral |
| 2021-06-30 | Barclays | Downgrade | Equal-Weight -> Underweight |
| 2021-06-15 | Needham | Downgrade | Buy -> Hold |
| 2021-04-23 | Wolfe Research | Initiate | Outperform |
| 2021-04-09 | Barclays | Maintains | Equal-Weight |
| 2021-02-16 | BMO Capital | Upgrade | Market Perform -> Outperform |
| 2021-02-10 | Needham | Maintains | Buy |
| 2021-02-10 | Wells Fargo | Maintains | Overweight |
| 2021-02-10 | Credit Suisse | Maintains | Neutral |
Next Earnings Forecast Details
Next Earnings Details
Release DateFeb 8, 2022
PeriodQ4 / 2023
EPS Estimate$0.33
Revenue Estimate407.7M
Revenue Q2Q21.30%
EPS Q2Q43.63%
Number of Analysts19
Next Earnings Revisions
Revenue (1 Month)
0.00%
Revenue (3 Months)
0.02%
EPS (1 Month)
0.00%
EPS (3 Months)
1.06%
Next Earnings Summary
CDAY.CA is expected to report earnings on 2/8/2022. The consensus EPS estimate for the next earnings is 0.33 CAD and the consensus revenue estimate is 407.70M CAD.
The next earnings revenue estimate has been revised upward by 0.02% in the past 3 months.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 842.5M 2.23% | 1.024B 21.57% | 1.246B 21.68% | 1.544B 23.90% | 1.774B 14.90% | 2.041B 15.05% | 2.434B 19.26% | 2.811B 15.49% | 3.219B 14.51% | 3.659B 13.67% | 4.129B 12.85% | |
| EBITDA YoY % growth | 56.9M -54.19% | 23.1M -59.40% | 54.7M 136.80% | 419.62M 667.13% | 501.72M 19.57% | 616.76M 22.93% | 842.52M 36.60% | 1.038B 23.20% | 1.254B 20.81% | 1.492B 18.98% | 1.748B 17.16% | |
| EBIT YoY % growth | 5.1M -92.40% | -54.4M -1,166.67% | -34.3M 36.95% | 341.29M 1,095.01% | 406.8M 19.19% | 510.72M 25.55% | 528.36M 3.45% | 610.98M 15.64% | 698.7M 14.36% | 792.54M 13.43% | 881.28M 11.20% | |
| Operating Margin | 0.61% | -5.31% | -2.75% | 22.10% | 22.93% | 25.02% | 21.71% | 21.74% | 21.71% | 21.66% | 21.34% | |
| EPS YoY % growth | 0.49 8.89% | 0.26 -46.94% | 0.77 196.15% | 1.36 76.11% | 1.72 26.67% | 2.15 25.46% | 3.68 70.88% | 4.56 23.82% | 5.52 21.03% | 6.57 19.04% | 7.69 17.08% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q4 / 23 | Q1 / 24 | Q2 / 24 | Q3 / 24 | Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.33 43.63% | 0.45 45.59% | 0.42 29.73% | 0.44 17.59% | 0.42 26.70% | 0.54 19.01% | 0.51 22.60% | 0.55 25.32% | 0.51 22.31% |
| Revenue Q2Q % growth | 407.7M 21.30% | 436.86M 17.88% | 429.74M 17.45% | 442.5M 17.22% | 461.92M 13.30% | 496.41M 13.63% | 489.98M 14.02% | 511.36M 15.56% | 526.62M 14.01% |
| EBITDA Q2Q % growth | 100.58M 5.65% | 127.86M 99.78% | 121.33M 54.56% | 124.82M 8.35% | 123.89M 23.18% | 156.54M 22.43% | 151.07M 24.51% | 157.82M 26.44% | 149.11M 20.36% |
| EBIT Q2Q % growth | 77.805M 1,154.92% | 105.35M 151.43% | 99.957M 201.98% | 102.84M 230.68% | 100.56M 29.25% | 133.93M 27.13% | 129.32M 29.38% | 134.46M 30.75% | 125.98M 25.28% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
40.92%
EPS Next 5 Year
42.72%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
17.44%
Revenue Next 5 Year
17.41%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
51.44%
EBIT Next 5 Year
42.35%
CERIDIAN HCM HOLDING INC / CDAY.CA Forecast FAQ
What do analysts expect the price target to be for CERIDIAN HCM HOLDING INC (CDAY.CA)?
24 analysts have analysed CDAY.CA and the average price target is 105.21 CAD. This implies a price increase of 14.01% is expected in the next year compared to the current price of 92.28.
What is the next earnings date for CDAY stock?
CERIDIAN HCM HOLDING INC (CDAY.CA) will report earnings on 2022-02-08.
What are the consensus estimates for CDAY stock next earnings?
The consensus EPS estimate for the next earnings of CERIDIAN HCM HOLDING INC (CDAY.CA) is 0.33 CAD and the consensus revenue estimate is 407.70M CAD.
What is the consensus rating for CDAY stock?
The consensus rating for CERIDIAN HCM HOLDING INC (CDAY.CA) is 76.6667 / 100 . This indicates that analysts generally have a positive outlook on the stock.